Advances in the Development of Antiviral Compounds for Rotavirus Infections
Group A rotaviruses (RVAs) are the major cause of severe acute gastroenteritis (AGE) in children under 5 years of age, annually resulting in nearly 130,000 deaths worldwide. Social conditions in developing countries that contribute to decreased oral rehydration and vaccine efficacy and the lack of...
Saved in:
Main Authors: | María Julieta Tohmé, Laura Ruth Delgui |
---|---|
Format: | article |
Language: | EN |
Published: |
American Society for Microbiology
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c4f9acf65eb1487e8b511935630f3f91 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stem Cell-Derived Human Intestinal Organoids as an Infection Model for Rotaviruses
by: Stacy R. Finkbeiner, et al.
Published: (2012) -
Rotavirus Infection and Cytopathogenesis in Human Biliary Organoids Potentially Recapitulate Biliary Atresia Development
by: Sunrui Chen, et al.
Published: (2020) -
Rotavirus Disrupts Calcium Homeostasis by NSP4 Viroporin Activity
by: Joseph M. Hyser, et al.
Published: (2010) -
Specificity and Mechanism of Coronavirus, Rotavirus, and Mammalian Two-Histidine Phosphoesterases That Antagonize Antiviral Innate Immunity
by: Abhishek Asthana, et al.
Published: (2021) -
A Vimentin-Targeting Oral Compound with Host-Directed Antiviral and Anti-Inflammatory Actions Addresses Multiple Features of COVID-19 and Related Diseases
by: Zhizhen Li, et al.
Published: (2021)